Short- and Long-Term Tracking of Anionic Ultrasmall Nanoparticles in Kidney.
暂无分享,去创建一个
M. Roberts | Z. Xu | J. Grice | Run Zhang | Haolu Wang | Xiaowen Liang | Xin Liu | V. Cogger | Yian Zhu
[1] Chor Yong Tay,et al. Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. , 2015, Chemical Society reviews.
[2] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[3] R. Stauber,et al. The nanoparticle biomolecule corona: lessons learned - challenge accepted? , 2015, Chemical Society reviews.
[4] Raimo Hartmann,et al. In vivo integrity of polymer-coated gold nanoparticles. , 2015, Nature nanotechnology.
[5] Jim E Riviere,et al. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice , 2015, Nanotoxicology.
[6] K. Hungerbuhler,et al. Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles , 2015, Nanotoxicology.
[7] Washington Y. Sanchez,et al. Intravital multiphoton imaging of the selective uptake of water-dispersible quantum dots into sinusoidal liver cells. , 2015, Small.
[8] Yousuf H. Mohammed,et al. Real-time histology in liver disease using multiphoton microscopy with fluorescence lifetime imaging. , 2015, Biomedical optics express.
[9] S. Dou,et al. Ultra-small fluorescent inorganic nanoparticles for bioimaging. , 2014, Journal of materials chemistry. B.
[10] Guannan Wang,et al. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging. , 2014, Nanoscale.
[11] Washington Y. Sanchez,et al. Multiphoton fluorescence microscopy of the live kidney in health and disease , 2014, Journal of biomedical optics.
[12] V. Castranova,et al. Lung toxicity and biodistribution of Cd/Se-ZnS quantum dots with different surface functional groups after pulmonary exposure in rats , 2013, Particle and Fibre Toxicology.
[13] G. Lu,et al. One-pot preparation of highly fluorescent cadmium telluride/cadmium sulfide quantum dots under neutral-pH condition for biological applications. , 2013, Journal of colloid and interface science.
[14] Rodney A. Hill,et al. Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[15] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[16] Mark E. Davis,et al. Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane , 2012, Proceedings of the National Academy of Sciences.
[17] M. Roberts,et al. Multiphoton microscopy can visualize zonal damage and decreased cellular metabolic activity in hepatic ischemia-reperfusion injury in rats. , 2011, Journal of biomedical optics.
[18] Chunhai Fan,et al. In vivo distribution, pharmacokinetics, and toxicity of aqueous synthesized cadmium-containing quantum dots. , 2011, Biomaterials.
[19] Zhiwei Sun,et al. Plasma kinetics and biodistribution of water-soluble CdTe quantum dots in mice: a comparison between Cd and Te , 2011 .
[20] Rebekah Drezek,et al. In vivo biodistribution of nanoparticles. , 2011, Nanomedicine.
[21] Dong Chen,et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.
[22] H. Soyer,et al. Applications of multiphoton tomographs and femtosecond laser nanoprocessing microscopes in drug delivery research. , 2011, Advanced drug delivery reviews.
[23] Mark E. Davis,et al. Targeting kidney mesangium by nanoparticles of defined size , 2011, Proceedings of the National Academy of Sciences.
[24] Kostas Kostarelos,et al. Physiologically based pharmacokinetic modeling of nanoparticles. , 2010, ACS nano.
[25] S. Gambhir,et al. Facile synthesis, silanization, and biodistribution of biocompatible quantum dots. , 2010, Small.
[26] Chin-Tu Chen,et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. , 2010, Biomaterials.
[27] Dan Cui,et al. Free cadmium ions released from CdTe-based nanoparticles and their cytotoxicity on Phaeodactylum tricornutum. , 2010, Metallomics : integrated biometal science.
[28] Indrajit Roy,et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.
[29] Yuesi Wang,et al. Intracellular oxidative stress and cadmium ions release induce cytotoxicity of unmodified cadmium sulfide quantum dots. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[30] W. Chan,et al. Visualizing quantum dots in biological samples using silver staining. , 2009, Analytical chemistry.
[31] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[32] A. Koretsky,et al. MRI of the basement membrane using charged nanoparticles as contrast agents , 2008, Magnetic resonance in medicine.
[33] R. Nitschke,et al. Quantum dots versus organic dyes as fluorescent labels , 2008, Nature Methods.
[34] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[35] Robert Sinclair,et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. , 2008, Small.
[36] Tsuneji Nagai,et al. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. , 2008, International journal of pharmaceutics.
[37] E. Fabian,et al. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats , 2008, Archives of Toxicology.
[38] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[39] J. Stockand,et al. Glomerular mesangial cells: electrophysiology and regulation of contraction. , 1998, Physiological reviews.
[40] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[41] M. Kashgarian,et al. The pathobiology of the mesangium. , 1992, Kidney international.
[42] Albert Farrugia,et al. Albumin usage in clinical medicine: tradition or therapeutic? , 2010, Transfusion medicine reviews.
[43] N. Gokden,et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. , 2007, American journal of physiology. Renal physiology.
[44] M. Bawendi,et al. Emission Intensity Dependence and Single-Exponential Behavior In Single Colloidal Quantum Dot Fluorescence Lifetimes , 2004 .